BriaCell Therapeutics Corp. Quarterly Share-based Payment Arrangement, Expense in USD from Q3 2022 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
BriaCell Therapeutics Corp. quarterly Share-based Payment Arrangement, Expense history and growth rate from Q3 2022 to Q1 2024.
  • BriaCell Therapeutics Corp. Share-based Payment Arrangement, Expense for the quarter ending April 30, 2024 was $392K, a 39.5% increase year-over-year.
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $392K +$111K +39.5% Feb 1, 2024 Apr 30, 2024 10-Q 2024-06-14
Q4 2023 $500K +$233K +87.4% Nov 1, 2023 Jan 31, 2024 10-Q 2024-03-18
Q3 2023 $534K -$578K -52% Aug 1, 2023 Oct 31, 2023 10-Q 2023-12-14
Q1 2023 $281K Feb 1, 2023 Apr 30, 2023 10-Q 2024-06-14
Q4 2022 $267K Nov 1, 2022 Jan 31, 2023 10-Q 2024-03-18
Q3 2022 $1.11M Aug 1, 2022 Oct 31, 2022 10-Q 2023-12-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.